
ELV News
Elevance Health Inc.
$421.49
-$9.83(-2.28%)
80
Overall
100
Value
91
Tech
50
Quality
Market Cap
$96.21B
Volume
1.54M
52W Range
$274.84 - $450.69
Target Price
$450.62
ELV news: the latest Elevance Health Inc. headlines, press releases and market updates, newest first.
Latest ELV News
- Elevra Lithium Delivers Record Quarter and Deepens North American FocusTipRanks Australian Auto-Generated Newsdesk · Oct 26, 2026
- Analysts’ Opinions Are Mixed on These Healthcare Stocks: Biogen (BIIB), Elevance Health (ELV) and Myriad Genetics (MYGN)TipRanks Newsroom · Oct 22, 2026
- Barclays Keeps Their Buy Rating on Elevance Health (ELV)TipRanks Auto-Generated Intelligence Newsdesk · Oct 22, 2026
- Analysts Conflicted on These Healthcare Names: Elevance Health (ELV), Moderna (MRNA) and Abbott Laboratories (ABT)TipRanks Newsroom · Oct 22, 2026
- Elevra Lithium Sets Date for September Quarter Results and Investor WebcastTipRanks Australian Auto-Generated Newsdesk · Oct 20, 2026
- Elevra Lithium Sets November Hybrid AGM and Details CEO Incentive GrantsTipRanks Auto-Generated Newsdesk · Oct 16, 2026
- Elevra Lithium Sets November Hybrid AGM and Details CEO Incentive GrantsTipRanks Auto-Generated Newsdesk · Oct 16, 2026
- Enliven Therapeutics Adds Director to Support GrowthTipRanks Auto-Generated Newsdesk · Oct 14, 2026
- Electrovaya Maps Record Revenue Year and Pivotal Expansion in U.S. Manufacturing and Data Center StorageTipRanks Canadian Auto-Generated Newsdesk · Oct 14, 2026
- 3 ETFs Tipped for 10% or More Gains by AI AnalystSolomon Oladipupo · Oct 13, 2026
- Ascend to Go Public via EvoNext Merger in CHF 500m Sports Tech DealTipRanks Switzerland Auto-Generated Newsdesk · Oct 12, 2026
- RBC Capital Keeps Their Hold Rating on Elevance Health (ELV)TipRanks Auto-Generated Intelligence Newsdesk · Oct 9, 2026
- Positive Report for Elevra Lithium (SYAXF) from UBSTipRanks Auto-Generated Intelligence Newsdesk · Oct 9, 2026
- Electrovaya Files October Form 6-K, Adds Legal and Audit Consents to F-10TipRanks Auto-Generated Newsdesk · Oct 8, 2026
- TD Cowen Remains a Buy on Enliven Therapeutics (ELVN)TipRanks Auto-Generated Intelligence Newsdesk · Oct 8, 2026
- Barclays Sticks to Their Buy Rating for Elevance Health (ELV)TipRanks Auto-Generated Intelligence Newsdesk · Oct 7, 2026
- Electrovaya Details 2026 AGM Agenda and Plan to Redomicile from Ontario to DelawareTipRanks Auto-Generated Newsdesk · Oct 5, 2026
- Elevra Lithium Details Approval Timeline for US$71m Ewoyaa Project SaleTipRanks Australian Auto-Generated Newsdesk · Sep 30, 2026
- EvoNext Posts Modest Loss as Talks Advance on Reverse Merger with Ascend Sport TechnologyTipRanks Switzerland Auto-Generated Newsdesk · Sep 30, 2026
- Guerbet Publishes 2026 Half-Year Financial Report Ahead of Q3 Revenue ReleaseTipRanks European Auto-Generated Newsdesk · Sep 29, 2026
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ELV | $421.49 | -2.3% | 1.54M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |